Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00670
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2003English

Comorbid Infections Induce Progression of Visceral Leishmaniasis

Parasites and Vectors
ParasitologyInfectious Diseases
2019English

Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects

Frontiers in Immunology
AllergyImmunology
2014English

Association Between Insulin-Like Growth Factor-I Levels and the Disease Progression and Anemia in Visceral Leishmaniasis

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2019English

Visceral Leishmaniasis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1993English

Neoepitopes as Cancer Immunotherapy Targets: Key Challenges and Opportunities

Immunotherapy
OncologyAllergyImmunology
2017English

Surveillance of Canine Visceral Leishmaniasis in a Disease-Free Area

Revista Brasileira de Parasitologia Veterinária
2010English

Non-Leishmania Parasite in Fatal Visceral Leishmaniasis–like Disease, Brazil

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2020English

Quantitative Clonal Barcode Analysis for the Identification of Key Drivers of Disease Progression and Drug Resistance

BioTechniques
BiochemistryBiotechnologyGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy